本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Finch Therapeutics Group, Inc.

13.21
+0.16001.23%
成交量:2,064.00
成交额:2.74万
市值:2,121.21万
市盈率:-1.50
高:13.35
开:13.05
低:13.05
收:13.05
数据加载中...
2024/11/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/11/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/11/01

员工持股计划

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2024/10/31

自愿退市

Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities
2024/10/21

重要事件披露

Form 8-K - Current report
2024/08/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/17

重要事件披露

Form 8-K - Current report
2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/26

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/04/03

重要事件披露

Form 8-K - Current report
2024/03/29

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/25

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/23

重要事件披露

Form 8-K - Current report
2023/12/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/17

重要事件披露

Form 8-K - Current report
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/11

[修订]季度报告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]